Position in ACRS
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$775,551
-$315,687 QoQ
Shares Held
206,814
-43.0% QoQ
Ownership
0.148%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.96663668803852.ToString("F0")%
Shared 0.ToString("F0")%
None 0.03336331196147263.ToString("F0")%
Common Shares in ACRS Over Time
Shares Held
Position Value (USD)
Derivatives in ACRS
reported options exposure · as of Jun 30, 2021CallValue
$0
CallShares
0
PutValue
$147,504
PutShares
8,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. ACRS ranks #262 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in ACRS
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $775,551 | 206,814 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,091,238 | 362,538 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $199,761 | 105,138 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $217,504 | 153,172 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $113,207 | 73,992 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $172,267 | 69,463 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $36,628 | 31,852 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $37,169 | 33,791 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $87,296 | 70,401 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $20,604 | 19,624 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $353,992 | 51,678 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $29,180 | 2,814 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $16,446 | 2,033 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $37,894 | 2,406 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $45,189 | 2,871 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $33,587 | 2,406 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $29,342 | 1,702 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $671,573 | 46,188 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $29,700 | 1,650 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $50,906 | 2,899 | Shares | Defined | 2021-08-13 | |
| 2021-06-30 | $147,504 | 8,400 | Put | Defined | 2021-08-13 | |
| 2021-03-31 | $160,423 | 6,366 | Shares | Defined | 2021-05-12 | |
| 2021-03-31 | $211,680 | 8,400 | Put | Defined | 2021-05-12 | |
| 2020-12-31 | $8,449 | 1,306 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $12,891 | 5,016 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $886 | 547 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $19,756 | 18,997 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||